AuroMedics Pharma LLC is recalling one lot of Gabapentin (gabapentin) Capsules, USP 100 mg, packaged in 1000-count bottles. The recall was initiated because a single tablet of a different medication, Losartan Potassium and Hydrochlorothiazide (HCTZ), was found inside a bottle of Gabapentin. This cross-contamination means a patient could accidentally take a blood pressure medication instead of their intended dose of Gabapentin, which is typically used for seizures or nerve pain. Consumers should check their prescription bottles immediately to see if their medication is part of the affected lot.
Taking an unintended dose of Losartan/HCTZ can cause a sudden and dangerous drop in blood pressure, kidney complications, or electrolyte imbalances. These risks are significantly higher for pregnant women or individuals already taking other blood pressure medications.
Return to pharmacy for refund and consult healthcare provider.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.